| $385M | ||
| $337M | ||
| $100M | ||
| $87M | ||
| $82M | ||
| $62M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. Artelo Biosciences, Inc. has research collaboration with Trinity College Dublin to investigate ART27.13 for the treatment of cancer cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.
Over the last 12 months, insiders at Artelo Biosciences, Inc. have bought $0 and sold $0 worth of Artelo Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Artelo Biosciences, Inc. have bought $9,723 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,200 shares for transaction amount of $4,800 was made by Gorgas Gregory D. (Pres, CEO, CFO, Treas & Secr) on 2022‑08‑12.
| 2022-08-12 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 1,200 0.0445% | $4.00 | $4,800 | -27.57% | ||
| 2022-08-11 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 1,200 0.0456% | $4.03 | $4,836 | -26.08% | ||
| 2021-04-16 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 8,500 0.0366% | $1.15 | $9,809 | -30.80% | ||
| 2020-05-15 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 4,200 0.1219% | $1.21 | $5,072 | -5.00% | ||
| 2020-05-04 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 4,167 0.1136% | $1.20 | $5,000 | -9.45% | ||
| 2020-05-04 | MATSUI CONNIE | director | 41,667 1.1357% | $1.20 | $50,000 | -9.45% | ||
| 2019-11-04 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 2,400 0.0701% | $2.21 | $5,304 | -45.78% | ||
| 2019-11-01 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 2,500 0.0823% | $2.28 | $5,702 | -40.29% | ||
| 2019-10-31 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 2,500 0.0729% | $1.95 | $4,875 | -38.19% | ||
| 2019-10-30 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 2,600 0.0771% | $1.99 | $5,186 | -38.50% | ||
| 2019-10-15 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 2,600 0.0793% | $2.05 | $5,333 | -37.50% | ||
| 2019-10-11 | Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 2,700 0.0796% | $1.96 | $5,296 | -36.87% |
| MATSUI CONNIE | director | 56667 2.807% | $116,734.02 | 1 | 0 | <0.0001% |
| Gorgas Gregory D. | Pres, CEO, CFO, Treas & Secr | 2400 0.1189% | $4,944.00 | 11 | 0 | <0.0001% |
$22,360,243 | 40 | 22.92% | $4.97M | |
$1,138,733 | 28 | -4.94% | $4.28M | |
$8,079,884 | 14 | -43.20% | $4.39M | |
Artelo Biosciences, Inc. (ARTL) | $105,917 | 11 | -28.06% | $4.16M |
$20,715,938 | 10 | -42.51% | $6.24M | |
$16,172 | 9 | -21.60% | $3.59M | |
$90,087 | 9 | 20.06% | $5.55M | |
$8,971,546 | 8 | 6.18% | $5.67M | |
$70,828 | 6 | -57.96% | $2.43M | |
$149,778 | 4 | -45.16% | $3.75M | |
$553,551 | 4 | -74.30% | $2.42M | |
$726,438 | 4 | -72.85% | $3.86M | |
$14,867 | 4 | -56.46% | $3.16M | |
$4,423 | 2 | 3.27% | $5.73M | |
$739,010 | 1 | 3.33% | $4.44M | |
$19,863 | 1 | 144.27% | $4.76M | |
$75,000 | 1 | -30.67% | $5.52M | |
$37,000 | 1 | 79.42% | $3.55M | |
$1,049,630 | 1 | -74.91% | $1.74M |
| Increased Positions | 8 | +160% | 32,934 | +198.54% |
| Decreased Positions | 2 | -40% | 16,479 | -99.34% |
| New Positions | 3 | New | 31,215 | New |
| Sold Out Positions | 2 | Sold Out | 16,479 | Sold Out |
| Total Postitions | 11 | +120% | 33,043 | +99.2% |
| Drw Securities, Llc | $30.00 | 0.86% | 17,185 | +17,185 | New | 2025-09-30 |
| Vanguard Group Inc | $24.00 | 0.7% | 14,028 | +14,028 | New | 2025-09-30 |
| Morgan Stanley | $2.00 | 0.06% | 1,100 | +1,096 | +27,400% | 2025-09-30 |
| Citigroup Inc | $1.00 | 0.02% | 477 | +468 | +5,200% | 2025-09-30 |
| Ubs Group Ag | $0 | 0.01% | 209 | +120 | +134.83% | 2025-09-30 |
| Fmr Llc | $0 | <0.01% | 30 | +29 | +2,900% | 2025-09-30 |
| Bank Of America Corp /De/ | $0 | <0.01% | 11 | +6 | +120% | 2025-09-30 |
| Rothschild Investment Llc | $0 | 0% | 2 | +2 | New | 2025-09-30 |
| Royal Bank Of Canada | $0 | 0% | 1 | 0 | 0% | 2025-09-30 |
| Geode Capital Management, Llc | $0 | 0% | 0 | -16,032 | Sold Out | 2025-09-30 |